Fidelity Investments
GYRE icon

Fidelity Investments’s Gyre Therapeutics GYRE Stock Holding History

Fidelity Investments’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$130K Buy
18,717
+8,413
+82% +$65.3K ﹤0.01% 3692
2025
Q4 		$72.7K Buy
10,304
+100
+1% +$772 ﹤0.01% 3916
2025
Q3 		$76.1K Sell
10,204
-688
-6% -$5.22K ﹤0.01% 3779
2025
Q2 		$80.1K Buy
10,892
+10,516
+2,797% +$91.7K ﹤0.01% 3698
2025
Q1 		$2.9K Sell
376
-880
-70% -$9.65K ﹤0.01% 4825
2024
Q4 		$15.2K Sell
1,256
-2,486
-66% -$31.8K ﹤0.01% 4299
2024
Q3 		$46.9K Buy
+3,742
New +$48.2K ﹤0.01% 3805
2023
Q2 		– Hold
0
– – – 5475
2023
Q1 		– Hold
0
– – – 5394
2021
Q4 		– Hold
0
– – – 4601
2021
Q3 		– Hold
0
– – – 4631
2021
Q2 		– Sell
-11
Closed – – 4511
2021
Q1 		$0 Hold
11
– – ﹤0.01% 4213
2020
Q4 		$1K Buy
+11
New +$476 ﹤0.01% 3692
2015
Q4 		– Sell
-350
Closed -$184K – 2745
2015
Q3 		$184K Sell
350
-372
-52% -$567K ﹤0.01% 2687
2015
Q2 		$1.59M Buy
722
+63
+10% +$126K ﹤0.01% 2481
2015
Q1 		$1.54M Sell
659
-16
-2% -$33K ﹤0.01% 2454
2014
Q4 		$1.4M Buy
675
+15
+2% +$28.9K ﹤0.01% 2489
2014
Q3 		$1.31M Buy
660
+164
+33% +$405K ﹤0.01% 2496
2014
Q2 		$1.76M Sell
496
-31
-6% -$101K ﹤0.01% 2423
2014
Q1 		$1.97M Sell
527
-19
-3% -$70.3K ﹤0.01% 2386
2013
Q4 		$1.78M Buy
546
+16
+3% +$63.1K ﹤0.01% 2372
2013
Q3 		$2.22M Sell
530
-5,384
-91% -$21.7M ﹤0.01% 2325
2013
Q2 		$19.9M Buy
+5,914
New +$22.5M ﹤0.01% 1666

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments's GYRE Position: Q1 2026 in Review

Fidelity Investments increased its Gyre Therapeutics (GYRE) stake by 82% in Q1 2026, buying an estimated $65.3K and bringing the position to 18,717 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #3692.

Fidelity Investments first reported a position in GYRE in Q2 2013 and has held it in 19 quarters since. The position peaked at $19.9M in Q2 2013. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

  • Fidelity Investments held 18,717 shares of Gyre Therapeutics worth $130K as of Q1 2026.
  • Fidelity Investments bought 8,413 Gyre Therapeutics shares in Q1 2026, an estimated $65.3K.
  • Gyre Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3692 holding.
  • Fidelity Investments first reported a position in Gyre Therapeutics in Q2 2013 and has held it in 19 quarters since.
  • Fidelity Investments's Gyre Therapeutics position peaked at $19.9M in Q2 2013.
  • 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.